Exploring non-surgical options for managing placenta accreta spectrum.
Conservative management as an alternative to hysterectomy for placenta accreta spectrum.
This study is looking at safer ways to manage placenta accreta spectrum, a serious pregnancy condition, so that women can keep their uterus and have better outcomes, and it’s led by Dr. Brett Einerson and his team who want to understand what matters most to patients during this process.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project ID | NIH-10892662 on NIH RePORTER |
What this research studies
This research investigates conservative management approaches for placenta accreta spectrum (PAS), a serious pregnancy condition that can lead to severe complications. The project aims to develop and evaluate treatment strategies that avoid hysterectomy, focusing on preserving the uterus and improving patient outcomes. Dr. Brett Einerson, a Maternal-Fetal Medicine physician, will work with a team of experts to design clinical trials and gather qualitative data to understand patient experiences and decision-making processes. The goal is to provide safer alternatives for women affected by PAS.
Who could benefit from this research
Good fit: Ideal candidates for this research are pregnant women diagnosed with placenta accreta spectrum who are considering treatment options.
Not a fit: Patients who have already undergone a hysterectomy or are not currently pregnant may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could offer women with placenta accreta spectrum safer treatment options that preserve their reproductive health.
How similar studies have performed: Previous research has shown promise in conservative management approaches for similar obstetric conditions, indicating potential for success in this area.
Where this research is happening
Salt Lake City, United States
- University of Utah — Salt Lake City, United States (Active)
Researchers
- Principal investigator: Einerson, Brett David — University of Utah
- Study coordinator: Einerson, Brett David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.